193 related articles for article (PubMed ID: 1540875)
1. Interleukin-6 dependence of advanced malignant plasma cell dyscrasias.
Zhang XG; Bataille R; Widjenes J; Klein B
Cancer; 1992 Mar; 69(6):1373-6. PubMed ID: 1540875
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.
Lu ZY; Zhang XG; Rodriguez C; Wijdenes J; Gu ZJ; Morel-Fournier B; Harousseau JL; Bataille R; Rossi JF; Klein B
Blood; 1995 May; 85(9):2521-7. PubMed ID: 7727780
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma and secondary plasma cell leukemia.
Dos Santos VM; Melim SP; de Faria PS; Passini VV; Duarte ML; Casasanta RA
Rom J Morphol Embryol; 2016; 57(2 Suppl):837-839. PubMed ID: 27833979
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
Bataille R; Jourdan M; Zhang XG; Klein B
J Clin Invest; 1989 Dec; 84(6):2008-11. PubMed ID: 2592570
[TBL] [Abstract][Full Text] [Related]
7. Response patterns of purified myeloma cells to hematopoietic growth factors.
Anderson KC; Jones RM; Morimoto C; Leavitt P; Barut BA
Blood; 1989 May; 73(7):1915-24. PubMed ID: 2713508
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.
Bergui L; Schena M; Gaidano G; Riva M; Caligaris-Cappio F
J Exp Med; 1989 Aug; 170(2):613-8. PubMed ID: 2787832
[TBL] [Abstract][Full Text] [Related]
9. Cytokine network in human multiple myeloma.
Klein B; Bataille R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):273-84. PubMed ID: 1582974
[TBL] [Abstract][Full Text] [Related]
10. gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro.
Portier M; Zhang XG; Caron E; Lu ZY; Bataille R; Klein B
Blood; 1993 Jun; 81(11):3076-82. PubMed ID: 8499642
[TBL] [Abstract][Full Text] [Related]
11. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.
Bataille R; Barlogie B; Lu ZY; Rossi JF; Lavabre-Bertrand T; Beck T; Wijdenes J; Brochier J; Klein B
Blood; 1995 Jul; 86(2):685-91. PubMed ID: 7605999
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the in vitro evolution of a myeloma cell line.
Scibienski RJ; Paglieroni T; Caggiano V; Lemongello D; Gumerlock PH; Mackenzie MR
Leukemia; 1992 Sep; 6(9):940-7. PubMed ID: 1518305
[TBL] [Abstract][Full Text] [Related]
13. Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.
Goto H; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Koishihara Y
Jpn J Cancer Res; 1994 Sep; 85(9):958-65. PubMed ID: 7961126
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma terminating in the leukemic stage with lobular nucleated eccentric plasma cells: a good response to therapy.
Otsuka T; Kimura N; Niho Y
Nihon Ketsueki Gakkai Zasshi; 1984 Feb; 47(1):150-7. PubMed ID: 6741429
[No Abstract] [Full Text] [Related]
15. Secondary plasma cell leukemia.
Rotaru I; Găman G; Dumitrescu D; Foarfă C
Rom J Morphol Embryol; 2012; 53(4):1073-6. PubMed ID: 23303035
[TBL] [Abstract][Full Text] [Related]
16. In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma.
Portier M; Rajzbaum G; Zhang XG; Attal M; Rusalen C; Wijdenes J; Mannoni P; Maraninchi D; Piechaczyk M; Bataille R
Eur J Immunol; 1991 Jul; 21(7):1759-62. PubMed ID: 2060582
[TBL] [Abstract][Full Text] [Related]
17. Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R; Montecucco CM; Ciotti R; Girino M
Cell Tissue Kinet; 1987 May; 20(3):311-8. PubMed ID: 3480077
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin gene rearrangement in multiple myeloma: limitations of Southern blot analysis.
Humphries JE; Dressman HK; Williams ME
Hum Pathol; 1991 Oct; 22(10):966-71. PubMed ID: 1842385
[TBL] [Abstract][Full Text] [Related]
19. Colony growth and self renewal of plasma cell precursors in multiple myeloma.
Takahashi T; Lim B; Jamal N; Tritchler D; Lockwood G; McKinney S; Bergsagel DE; Messner HA
J Clin Oncol; 1985 Dec; 3(12):1613-23. PubMed ID: 4067612
[TBL] [Abstract][Full Text] [Related]
20. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
